文献速递其他结缔组织病

原发性干燥综合征中CD161+CD4+T细胞RORγ阳性与阴性亚群的临床相关性

Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2016-11-01

本研究通过比较流式细胞术定量分析原发性干燥综合征(pSS)患者外周血中CD161+CD4+T细胞的RORγ表达与不表达亚群,发现两亚群频率均升高,但RORγ+亚群与体液表现(抗SSA/SSB抗体和高丙种球蛋白血症)正相关,而RORγ-亚群与疾病活动度相关。唇腺活检显示HLA-DR+CD161+CD4+T细胞频率增加,提示靶组织内慢性激活。

要点

  • pSS患者外周血CD161+CD4+T细胞的RORγ+和RORγ-亚群频率均升高。
  • RORγ+亚群与体液表现(抗SSA/SSB抗体、高丙种球蛋白血症)正相关,与疾病活动度无关。
  • RORγ-亚群与疾病活动度相关,与体液表现无关。

核心结论

  • CD161可作为pSS患者CD4+T细胞致病亚群的标志物。
  • RORγ+(Th17)CD161+亚群可能参与疾病体液表现,而RORγ-(非Th17)CD161+亚群与疾病活动度相关。

研究设计与样本

  • 比较流式细胞术定量分析外周血单核细胞中CD161和RORγ表达T细胞频率,样本为分层明确的pSS患者和对照者。
  • 分析9例接受诊断性活检者唇腺组织中HLA-DR和CD161的表达。

主要发现

  • pSS患者外周血CD161+CD4+T细胞的RORγ+和RORγ-亚群频率均增加。
  • RORγ+亚群增加与抗SSA/SSB自身抗体和高丙种球蛋白血症正相关,与疾病活动度无关。
  • RORγ-亚群增加与疾病活动度相关,与体液表现无关。
  • pSS患者唇腺活检中HLA-DR+CD161+CD4+T细胞频率增加,提示靶组织内CD161+CD4+T细胞慢性激活。

临床怎么用

  • RORγ+与RORγ-亚群分别对应pSS的体液表现和疾病活动度,提示临床评估时需区分CD161+CD4+T细胞亚群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The relevance of the Th17 pathway in primary SS (pSS) is unclear. Published studies have relied on restimulating circulating CD161+ T cells in vitro for quantitation of IL-17-producing cells. While CD161 marks all IL-17+ T cells, it is also expressed by other Th subsets. The aim of this study was to directly analyse retinoic acid receptor-related orphan nuclear receptor (ROR)-γ expressing and non-expressing subsets of CD161+ T cells to determine the relevance of the Th17 pathway in pSS. METHODS: We quantitated the frequencies of both CD161- and RORγ-expressing T cells by comparative flow cytometry in peripheral blood mononuclear cells from a well-stratified cohort of pSS patients and control subjects. We also analysed the expression of antigen D-related HLA (HLA-DR) and CD161 in labial salivary glands from nine subjects undergoing a diagnostic biopsy. RESULTS: While the frequencies of both RORγ+ and RORγ- subsets of CD161+ CD4+ T cells were increased in peripheral blood from pSS patients, the increase in the RORγ+ subset positively correlated with humoral manifestations of the disease (anti-SSA/SSB autoantibodies and hypergammaglobulinaemia), but not with disease activity, and vice versa for the RORγ- subset. An increased frequency of HLA-DR+ CD161+CD4+ T cells was observed in labial salivary gland biopsies from pSS patients, suggesting chronic activation of CD161+CD4+ T cells in the target tissue of the disease. CONCLUSION: In addition to pointing to CD161 as a marker of a pathogenic subset of CD4+ T cells in pSS patients, our data indicate that even though the RORγ+ (Th17) CD161+ subset might contribute to humoral manifestations of the disease, the RORγ- (non-Th17) CD161+ subset is the one associated with disease activity in pSS patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhao L, Nocturne G, Haskett S, et al. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome. Rheumatology (Oxford). 2016. PMID: 27803305. doi:10.1093/rheumatology/kew360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。